Literature DB >> 34088774

Relative Strengths of Three Linearizations of Receptor Availability: Saturation, Inhibition, and Occupancy Plots.

Javad Khodaii1,2, Mostafa Araj-Khodaei2, Manouchehr S Vafaee3,4,5, Dean F Wong6, Albert Gjedde7,5,8,9,10.   

Abstract

We derived three widely used linearizations from the definition of receptor availability in molecular imaging with positron emission tomography (PET). The purpose of the present research was to determine the convergence of the results of the 3 methods in terms of 3 parameters-occupancy (s), distribution volume of the nondisplaceable reference binding compartment (VND), and nondisplaceable reference binding potential (BPND) of the radioligand-in the absence of a gold standard. We tested 104 cases culled from the literature and calculated the goodness of fit of the least-squares and Deming II methods of linear regression when applied to the determination of s, VND, and BPND using the goodness-of-fit parameters R 2, coefficient of variation (root-mean-square error [RMSE]), and the infinity norm (‖X‖∞) with both regression methods. We observed superior convergence among the values of s, VND, and BPND for the inhibition and occupancy plots. The inhibition plot emerged as the plot with a slightly higher degree of convergence (based on R 2, RMSE, and ‖X‖∞ value). With two regression methods (the least-squares method [LSM] and the Deming II [DM] method), the estimated values of s, VND, and BPND generally converged. The inhibition and occupancy plots yielded the best fits to the data, according to the goodness-of-fit parameters, due primarily to absence of commingling of the dependent and independent variables tested with the saturation (original Lassen) plot. In the presence of noise, the inhibition and occupancy plots yielded higher convergences.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  Lassen plots; PET; binding potential; inhibition plot

Mesh:

Substances:

Year:  2021        PMID: 34088774      PMCID: PMC8805780          DOI: 10.2967/jnumed.117.204453

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  34 in total

Review 1.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

2.  Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited.

Authors:  Vincent J Cunningham; Eugenii A Rabiner; Mark Slifstein; Marc Laruelle; Roger N Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-09       Impact factor: 6.200

Review 3.  Current status of PET in breast cancer imaging, staging, and therapy.

Authors:  R L Wahl
Journal:  Semin Roentgenol       Date:  2001-07       Impact factor: 0.800

4.  Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.

Authors:  D F Wong; A Gjedde; H N Wagner
Journal:  J Cereb Blood Flow Metab       Date:  1986-04       Impact factor: 6.200

5.  In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.

Authors:  Matthew S Milak; Alin J Severance; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; R Todd Ogden; J John Mann; Ramin V Parsey
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-23       Impact factor: 6.200

6.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

Authors:  M A Mintun; M E Raichle; M R Kilbourn; G F Wooten; M J Welch
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

7.  Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.

Authors:  Rajesh Narendran; N Scott Mason; Chi-Min Chen; Michael Himes; Patrick Keating; Maureen A May; Eugenii A Rabiner; Marc Laruelle; Chester A Mathis; W Gordon Frankle
Journal:  Synapse       Date:  2011-04-26       Impact factor: 2.562

8.  Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers.

Authors:  Meret Martin-Facklam; Flavia Pizzagalli; Yun Zhou; Susanne Ostrowitzki; Vanessa Raymont; James R Brašić; Nikhat Parkar; Daniel Umbricht; Robert F Dannals; Ron Goldwater; Dean F Wong
Journal:  Neuropsychopharmacology       Date:  2012-11-07       Impact factor: 7.853

9.  Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.

Authors:  Dean F Wong; Hiroto Kuwabara; Andrew G Horti; Joshua M Roberts; Ayon Nandi; Nicola Cascella; James Brasic; Elise M Weerts; Kelly Kitzmiller; Jenny A Phan; Lorena Gapasin; Akira Sawa; Heather Valentine; Gary Wand; Chakradhar Mishra; Noble George; Michael McDonald; Wojtek Lesniak; Daniel P Holt; Babak B Azad; Robert F Dannals; William Kem; Robert Freedman; Albert Gjedde
Journal:  Int J Neuropsychopharmacol       Date:  2018-07-01       Impact factor: 5.176

10.  Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study.

Authors:  David R Owen; Qi Guo; Nicola J Kalk; Alessandro Colasanti; Dimitra Kalogiannopoulou; Rahul Dimber; Yvonne L Lewis; Vincenzo Libri; Julien Barletta; Joaquim Ramada-Magalhaes; Aruloly Kamalakaran; David J Nutt; Jan Passchier; Paul M Matthews; Roger N Gunn; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

View more
  1 in total

1.  Four decades of mapping and quantifying neuroreceptors at work in vivo by positron emission tomography.

Authors:  Albert Gjedde; Dean F Wong
Journal:  Front Neurosci       Date:  2022-09-08       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.